Tag Archives: Lufthansa

Lawyer for Germanwings Crash Victims Considering US Venue for Lawsuit

Elmar Giemulla, the lawyer representing 39 families whose loved ones died in the Germanwings plane crash is weighing the possibility of taking his lawsuit to the United States. The advantage to moving the lawsuit to the US is American law allows for much larger settlements than in Germany.

Prosecutors who have investigated the March crash of the A320 Airbus have come to the conclusion that the co-pilot intentionally crashed the plane, killing all 150 people on board. The plane was flying from Barcelona to Duesseldorf.

Two of the victims were American citizens, and the co-pilot did some of his training in the United States. These facts, according to Giemulla, will allow him to bring his lawsuit to the US. The advantage to suing in the US is that much more money can be collected, for instance, the deceased future earnings and the emotional damage done by the event can be calculated into the settlement. In Germany, where more than half of the victims had citizenship, does not allow those calculations.

Lufthansa, which owns Germanwings, has already offered the victims’ families about $108,000 per family, depending on the size of the family. Giemulla says that offer is way too low. He does say that he will discuss the issue again with Lufthansa before he files any lawsuit.

Franz Replacing Humer at Roche Next Year

New Chairman of Roche, Christoph Franz
New Chairman of Roche, Christoph Franz

Pharmaceutical giant and the world’s largest producer of anti-cancer drugs, Roche Holding AG, is hiring the chief executive officer of Deutsche Lufthansa AG, Christoph Franz. He will be taking the place of Chairman Franz Humer beginning next year.

The nomination of Franz will be presented to the shareholders at the annual shareholder meeting to be held on March 4, 2014. Franz’s contract with Lufthansa will end on May 31.
The outgoing chairman, Humer, has led Roche for over ten years, is given the credit for leading Roche’s unique strategy of coupling its diagnostics and drugs groups together to create boutique medications which can be targeted to individual patients.

Humer is 67, and was CEO when Roche purchased a 30 percent stake in the US biotech company Genentech Inc in 1999. Ten years later Humer helped to oversee the complete takeover of the company as chairman. The buyout allowed Roche to acquire its best-selling oncology drugs Rituxan and Herceptin. Herceptin is the company’s flagship “personalized” tumor treatment. It is an anti-breast cancer medication which is teamed up with a diagnostic test which reveals which women it is most likely to help.

Christoph Franz is 53 and has been the CEO of Lufthansa since 2011. Before that he was the CEO of Swiss International Airlines.